Latest period
$152M
YoY change
-22.8%
5Y CAGR
+46.8%
Peak year (FY2024)
$217M
Latest annual
$168M
Total Assets history chart for Climb Bio (CLYM) from 2019 to 2025
Latest: $168M
Total Assets growth chart for Climb Bio (CLYM) from 2019 to 2025
Latest: -22.8%
Total Assets history table for Climb Bio (CLYM) from 2019 to 2025
| FY2025 | $168M | -22.8% | -$49.4M | ||
| FY2024 | $217M | +96.6% | +$107M | ||
| FY2023 | $110M | -18.2% | -$24.5M | ||
| FY2022 | $135M | -22.1% | -$38.2M | ||
| FY2021 | $173M | +603.3% | +$149M | ||
| FY2020 | $24.6M | +15.1% | +$3.24M | ||
| FY2019 | $21.4M | — | — |
- FY2025$168M-22.8%
- FY2024$217M+96.6%
- FY2023$110M-18.2%
- FY2022$135M-22.1%
- FY2021$173M+603.3%
- FY2020$24.6M+15.1%
- FY2019$21.4M—
Total Assets values are taken from Climb Bio's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Climb Bio (CLYM)
According to Climb Bio's latest reported financial statements, the company's latest reported total assets is $152M. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Climb Bio (CLYM) total assets totalled $168M – declined 22.8% year-over-year.
Climb Bio total assets has grown on net over the period, with a +46.8% compound annual growth rate over 2020–2025 (5 years).
Climb Bio total assets peaked at $217M in 2024; the latest annual figure is $168M in 2025 (22.8% below peak).
The record annual total assets stands at $217M, reached in 2024; the historical low of $21.4M was recorded in 2019.
Climb Bio Total Assets by Year
Climb Bio Total Assets 2025: $168M
Climb Bio posted total assets of $168M in 2025, declined 22.8% below 2024.
Climb Bio Total Assets 2024: $217M
In 2024, Climb Bio reported total assets of $217M, surged 96.6% from 2023. This figure represents the highest annual value in the available history.
Climb Bio Total Assets 2023: $110M
Climb Bio total assets in 2023 was $110M, declined 18.2% below 2022.
Climb Bio Total Assets 2022: $135M
2022's total assets for Climb Bio came in at $135M, declined 22.1% below 2021.
Climb Bio Total Assets 2021: $173M
Climb Bio total assets in 2021 was $173M.
See more financial history for Climb Bio (CLYM).
Sector peers by Total Assets
Healthcare peers of Climb Bio (CLYM), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on CLYM
Market Cap — 10 rounds, every one of them CLYM against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.